logo
US issues expedited permit for proposed Tennessee coal mine

US issues expedited permit for proposed Tennessee coal mine

Reuters08-07-2025
July 8 (Reuters) - The Trump administration said it permitted a proposed coal mine in Claiborne County, Tennessee on Tuesday under an expedited process aimed at accelerating federal environmental reviews of energy projects.
In a statement, the Department of the Interior said it granted approval for Hurricane Creek Mining LLC to mine coal on Bryson Mountain in Claiborne County, Tennessee. The mine will produce up to 1.8 million tons of coal over the next decade, the agency said. The site was previously mined at various times between the 1950s and 2010.
The rushed permit is aligned with President Donald Trump's goal to increase coal mining as part of his energy dominance agenda.
The project is on private land but under federal law must be permitted by Interior's Office of Surface Mining Reclamation and Enforcement.
Hurricane Creek Mining could not immediately be reached for comment.
In April, Interior said it would implement an emergency permitting process for energy and mining projects, slashing approval times that typically take months or years to 28 days.
The department took another action this week to support coal. Interior's Bureau of Land Management on Monday said it is taking public comment on opening up coal leasing on public lands in the Powder River Basin in Montana and Wyoming. Comments will be taken through August 7 on opening up lands that former President Joe Biden put off-limits to leasing.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

China's exports top forecasts as shippers rush to meet tariff deadline
China's exports top forecasts as shippers rush to meet tariff deadline

Reuters

timea few seconds ago

  • Reuters

China's exports top forecasts as shippers rush to meet tariff deadline

BEIJING, Aug 7 (Reuters) - China's exports beat forecasts in July, as manufacturers made the most of a fragile tariff truce between Beijing and Washington to ship goods, especially to Southeast Asia, before tougher U.S. duties targeting transshipment take effect. Global traders and investors are waiting to see whether the world's two largest economies can agree on a durable trade deal by August 12 or if global supply chains will again be upended by the return of import levies exceeding 100%. U.S. President Donald Trump has raised the prospect of further tariffs, including a 40% duty on goods rerouted to the U.S. via transit hubs, that took effect on Thursday, as well as a 100% levy on chips and pharmaceutical products, and an additional 25% tax on goods from countries that buy Russian oil. China's outbound shipments rose 7.2% year-on-year in July, customs data showed on Thursday, beating a forecast 5.4% increase in a Reuters poll of economists and accelerating from June's 5.8% growth. China's trade war truce with the U.S. - the world's top consumer market - ends next week, although Trump hinted further tariffs may come Beijing's way due to its continuing purchases of Russian hydrocarbons. Imports grew 4.1%, defying economists' expectations for a 1.0% fall and climbing from a 1.1% rise in June, pointing to improving domestic demand as policymakers step up efforts to encourage households to boost spending. "The trade data suggests that the Southeast Asian markets play an ever more important role in U.S.-China trade," said Xu Tianchen, senior economist at the Economist Intelligence Unit. "But it's not all about the transshipments that Trump seeks to stop, ASEAN countries are also importing raw materials and components from China before exporting finished products to the U.S.," he added. China's exports to the U.S. fell 21.67% last month from a year earlier, the data showed, while shipments to ASEAN rose 16.59% over the same period. Trump said on Tuesday the U.S. was close to a trade deal with China and that he would meet his Chinese counterpart Xi Jinping before the end of the year if the world's two largest economies could come to an agreement. China's July trade surplus narrowed to $98.24 billion from $114.77 billion in June. Separate data from the U.S. Commerce Department's Bureau of Economic Analysis on Tuesday showed the U.S. trade gap with China shrank to its lowest in more than 21 years in June. Chinese government advisers are stepping up calls to make the household sector's contribution to broader economic growth a top priority at Beijing's upcoming five-year policy plan, as trade tensions and deflation threaten the outlook. And top leaders have vowed to step up regulation of aggressive price-cutting by Chinese companies that is pushing prices ever lower. But economists warn that reversing the current deflationary slump will be far more difficult than during the last round of supply-side reforms a decade ago, as the downturn now poses a broader threat to employment, which Chinese leaders have emphasised is a core component of social stability. Reaching an agreement with the United States — and with the European Union, which has accused China of producing and selling goods too cheaply — would give Chinese officials more room to advance their reform agenda. However, analysts expect little relief from Western trade pressures. Export growth is projected to slow sharply in the second half of the year, hurt by persistently high tariffs, President Trump's renewed crackdown on the rerouting of Chinese shipments and deteriorating relations with the EU.

Japanese investors ditch foreign stocks on US economic concerns, tariff tensions
Japanese investors ditch foreign stocks on US economic concerns, tariff tensions

Reuters

timea few seconds ago

  • Reuters

Japanese investors ditch foreign stocks on US economic concerns, tariff tensions

Aug 7 (Reuters) - Japanese investors significantly sold foreign stocks in the week to August 2 as major markets retreated on caution over U.S. economic outlook and a new set of trade tariffs. According to data from Japan's Ministry of Finance released on Thursday, domestic investors withdrew a net 752.1 billion yen ($5.10 billion) out of foreign stocks last week, reversing two successive weeks of net purchases. The MSCI World Index (.MIWD00000PUS), opens new tab lost a sharp 2.54% last week, the most in three months, pressured by a disappointing U.S. jobs report for July, and President Donald Trump's new round of punishing tariffs on dozens of countries. Despite the recent withdrawals, overseas stock markets have still received a massive 3.37 trillion yen worth of Japanese investments so far this year compared with a net 915.8 billion yen sales a year ago. They also sold foreign long-term bonds of 526.3 billion yen for the second successive week on the run. Meanwhile, Japanese stock markets saw approximately 193 billion yen in weekly net investments from overseas, the smallest amount in six weeks. In local bond markets, foreign outflows from long-term bonds cooled to a three-week low of 87.5 billion yen. Short-term bills saw 1.2 trillion yen of net foreign inflows after a net 1.95 trillion yen weekly outflow in the previous week. ($1 = 147.5800 yen)

Harvard scientists say research could be set back years after funding freeze
Harvard scientists say research could be set back years after funding freeze

The Independent

time30 minutes ago

  • The Independent

Harvard scientists say research could be set back years after funding freeze

Harvard University professor Alberto Ascherio's research is literally frozen. Collected from millions of U.S. soldiers over two decades using millions of dollars from taxpayers, the epidemiology and nutrition scientist has blood samples stored in liquid nitrogen freezers within the university's T.H. Chan School of Public Health. The samples are key to his award-winning research, which seeks a cure to multiple sclerosis and other neurodegenerative diseases. But for months, Ascherio has been unable to work with the samples because he lost $7 million in federal research funding, a casualty of Harvard's fight with the Trump administration. 'It's like we have been creating a state-of-the-art telescope to explore the universe, and now we don't have money to launch it,' said Ascherio. 'We built everything and now we are ready to use it to make a new discovery that could impact millions of people in the world and then, 'Poof. You're being cut off.'' Researchers laid off and science shelved The loss of an estimated $2.6 billion in federal funding at Harvard has meant that some of the world's most prominent researchers are laying off young researchers. They are shelving years or even decades of research, into everything from opioid addiction to cancer. And despite Harvard's lawsuits against the administration, and settlement talks between the warring parties, researchers are confronting the fact that some of their work may never resume. The funding cuts are part of a monthslong battle that the Trump administration has waged against some the country's top universities including Columbia, Brown and Northwestern. The administration has taken a particularly aggressive stance against Harvard, freezing funding after the country's oldest university rejected a series of government demands issued by a federal antisemitism task force. The government had demanded sweeping changes at Harvard related to campus protests, academics and admissions — meant to address government accusations that the university had become a hotbed of liberalism and tolerated anti-Jewish harassment. Research jeopardized, even if court case prevails Harvard responded by filing a federal lawsuit, accusing the Trump administration of waging a retaliation campaign against the university. In the lawsuit, it laid out reforms it had taken to address antisemitism but also vowed not to 'surrender its independence or relinquish its constitutional rights.' 'Make no mistake: Harvard rejects antisemitism and discrimination in all of its forms and is actively making structural reforms to eradicate antisemitism on campus," the university said in its legal complaint. 'But rather than engage with Harvard regarding those ongoing efforts, the Government announced a sweeping freeze of funding for medical, scientific, technological, and other research that has nothing at all to do with antisemitism.' The Trump administration denies the cuts were made in retaliation, saying the grants were under review even before the demands were sent in April. It argues the government has wide discretion to cancel federal contracts for policy reasons. The funding cuts have left Harvard's research community in a state of shock, feeling as if they are being unfairly targeted in a fight has nothing to do with them. Some have been forced to shutter labs or scramble to find non-government funding to replace lost money. In May, Harvard announced that it would put up at least $250 million of its own money to continue research efforts, but university President Alan Garber warned of 'difficult decisions and sacrifices' ahead. Ascherio said the university was able to pull together funding to pay his researchers' salaries until next June. But he's still been left without resources needed to fund critical research tasks, like lab work. Even a year's delay can put his research back five years, he said. Knowledge lost in funding freeze 'It's really devastating,' agreed Rita Hamad, the director of the Social Policies for Health Equity Research Center at Harvard, who had three multiyear grants totaling $10 million canceled by the Trump administration. The grants funded research into the impact of school segregation on heart health, how pandemic-era policies in over 250 counties affected mental health, and the role of neighborhood factors in dementia. At the School of Public Health, where Hamad is based, 190 grants have been terminated, affecting roughly 130 scientists. 'Just thinking about all the knowledge that's not going to be gained or that is going to be actively lost," Hamad said. She expects significant layoffs on her team if the funding freeze continues for a few more months. "It's all just a mixture of frustration and anger and sadness all the time, every day." John Quackenbush, a professor of computational biology and bioinformatics at the School of Public Health, has spent the past few months enduring cuts on multiple fronts. In April, a multimillion dollar grant was not renewed, jeopardizing a study into the role sex plays in disease. In May, he lost about $1.2 million in federal funding for in the coming year due to the Harvard freeze. Four departmental grants worth $24 million that funded training of doctoral students also were cancelled as part of the fight with the Trump administration, Quackenbush said. 'I'm in a position where I have to really think about, 'Can I revive this research?'' he said. 'Can I restart these programs even if Harvard and the Trump administration reached some kind of settlement? If they do reach a settlement, how quickly can the funding be turned back on? Can it be turned back on?' The researchers all agreed that the funding cuts have little or nothing to do with the university's fight against antisemitism. Some, however, argue changes at Harvard were long overdue and pressure from the Trump administration was necessary. Bertha Madras, a Harvard psychobiologist who lost funding to create a free, parent-focused training to prevent teen opioid overdose and drug use, said she's happy to see the culling of what she called 'politically motivated social science studies.' White House pressure a good thing? Madras said pressure from the White House has catalyzed much-needed reform at the university, where several programs of study have 'really gone off the wall in terms of being shaped by orthodoxy that is not representative of the country as a whole.' But Madras, who served on the President's Commission on Opioids during Trump's first term, said holding scientists' research funding hostage as a bargaining chip doesn't make sense. 'I don't know if reform would have happened without the president of the United States pointing the bony finger at Harvard," she said. 'But sacrificing science is problematic, and it's very worrisome because it is one of the major pillars of strength of the country.' Quackenbush and other Harvard researchers argue the cuts are part of a larger attack on science by the Trump administration that puts the country's reputation as the global research leader at risk. Support for students and post-doctoral fellows has been slashed, visas for foreign scholars threatened, and new guidelines and funding cuts at the NIH will make it much more difficult to get federal funding in the future, they said. It also will be difficult to replace federal funding with money from the private sector. 'We're all sort of moving toward this future in which this 80-year partnership between the government and the universities is going to be jeopardized,' Quackenbush said. 'We're going to face real challenges in continuing to lead the world in scientific excellence.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store